@Prof_NickTalley Should the Rome Foundation aggressively raise awareness among clinicians and the public about entities like bile acid diarrhea, or does the overemphasis on symptom-based diagnoses like IBS hinder the identification and treatment of this (and other) clinical entities?
In April 1955, a nurse held up a newspaper for a polio patient so he could read the headline...the disease that paralyzed him had finally been beaten.
Vaccines came too late for him. But they did come in time for millions of others. Let's never forget that.
@Prof_NickTalley It's good to see a critical reading on diagnoses defined by symptom clusters and expert opinion rather than identified pathophysiology. But, as Dr. Camilleri states, today it is possible to remove (some) BS from IBS (at least IBS-D) and use actionable biomarkers and targeted tx.
She can write! America not so great. Sussan Ley’s Route 83 Greyhound bus trip through middle USA helps her refocus her perspectives after Libs brutally dump her as leader. 👇👇AFR
IBS impacts the elderly including Parkinson disease. Irritable bowel syndrome in the elderly: epidemiology, diagnosis, treatment, and relationship with frailty - PubMed https://t.co/iwQujXP6zr
Latest from my group on the duodenal mucosa associated microbiome and gut dysfunction. Duodenal microbiota profiling and its effects on gastrointestinal tract dysfunction - PubMed https://t.co/TZoA0HeseB
Important study that will guide future interventions. Shared functional microbiome signatures in Parkinson's disease and constipation predominate irritable bowel syndrome despite taxonomic divergence - PubMed https://t.co/0A7hRwIqCk
A must read update. Clinical Practice Update for the Management of Patients With Disorders of Gut-Brain Interaction and Altered Food Intake Behavior - PubMed https://t.co/j68Xfq6c1H
An up to date guideline from my colleagues and me. Gastroenterological Society of Australia Position Statement on the Assessment and Management of Idiopathic Gastroparesis - PubMed https://t.co/3WV64NTqo6
My latest paper. Inaugural Rome Foundation Research into the Epidemiology of All Disorders of Gut-Brain Interaction: The 1993 U.S. Householder Survey in Digestive Diseases and Sciences, a High-Cite Classic - PubMed https://t.co/Axcm4zrorD
We show that Rome V identify a different population of patients from Rome III and Rome IV and their performance is different in diagnosing #IBS.
A summary of this diagnostic accuracy study is provided below
Europe’s wildfires are a warning: climate policy is health policy.
A new Lancet Editorial calls for health to be at the centre of wildfire preparedness and climate policy.
Read this & more: https://t.co/SqEJGCPSJA
Many people living with gastroparesis experience symptoms that others can't see—pain, nausea, bloating, vomiting, fatigue, and malnutrition can all happen behind a smile. Share this post to help raise awareness today.
#MoreThanInvisible#GastroparesisAwareness
Our paper reporting performance of Rome V criteria for #IBS is published in @LancetGastroHep and is free to download here:
The Rome V criteria for the diagnosis of irritable bowel syndrome in secondary care: a diagnostic accuracy study - The Lancet Gastroenterology & Hepatology